Scarica l'app Stockscreener
20.59
1.03%
0.21
Dopo l'orario di chiusura:
20.59
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CPRX Giù?
Forum
Previsione
Precedente Chiudi:
$20.38
Aprire:
$20.44
Volume 24 ore:
814.35K
Relative Volume:
0.60
Capitalizzazione di mercato:
$2.52B
Reddito:
$460.48M
Utile/perdita netta:
$142.80M
Rapporto P/E:
17.45
EPS:
1.18
Flusso di cassa netto:
$221.79M
1 W Prestazione:
-2.32%
1M Prestazione:
-2.02%
6M Prestazione:
-4.94%
1 anno Prestazione:
+3.05%
Intervallo 1D:
$20.39
$20.66
Intervallo di 1 settimana:
$19.83
$21.82
Portata 52W:
$19.00
$26.58
Catalyst Pharmaceuticals Inc Stock (CPRX) Company Profile
Nome
Catalyst Pharmaceuticals Inc
Settore
Industria
Telefono
(305) 529-2522
Indirizzo
355 ALHAMBRA CIRCLE, CORAL GABLES
Confronta CPRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CPRX
Catalyst Pharmaceuticals Inc
|
20.59 | 2.49B | 460.48M | 142.80M | 221.79M | 1.18 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Catalyst Pharmaceuticals Inc Stock (CPRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-04 | Iniziato | Robert W. Baird | Outperform |
| 2024-11-18 | Iniziato | Stephens | Overweight |
| 2024-03-14 | Iniziato | Citigroup | Buy |
| 2024-03-07 | Iniziato | BofA Securities | Buy |
| 2023-12-21 | Iniziato | Oppenheimer | Outperform |
| 2022-08-24 | Downgrade | ROTH Capital | Buy → Neutral |
| 2018-09-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-09-07 | Ripresa | Piper Jaffray | Overweight |
| 2016-10-05 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2016-04-26 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2014-09-30 | Reiterato | ROTH Capital | Buy |
| 2014-09-16 | Reiterato | ROTH Capital | Buy |
| 2014-09-15 | Reiterato | H.C. Wainwright | Buy |
| 2013-10-21 | Reiterato | Aegis Capital | Buy |
| 2013-09-24 | Iniziato | Maxim Group | Buy |
| 2013-09-06 | Reiterato | Aegis Capital | Buy |
| 2013-04-18 | Iniziato | Aegis Capital | Buy |
| 2012-08-27 | Aggiornamento | Rodman & Renshaw | Mkt Perform → Mkt Outperform |
| 2009-10-01 | Aggiornamento | Merriman | Sell → Neutral |
| 2009-05-29 | Downgrade | Hapoalim | Neutral → Underperform |
| 2009-05-29 | Downgrade | Merriman Curhan Ford | Buy → Sell |
| 2008-12-15 | Iniziato | Merriman Curhan Ford | Buy |
| 2007-11-28 | Iniziato | Rodman & Renshaw | Mkt Outperform |
| 2007-01-31 | Iniziato | Stifel Nicolaus | Buy |
| 2007-01-05 | Iniziato | First Albany | Buy |
Mostra tutto
Catalyst Pharmaceuticals Inc Borsa (CPRX) Ultime notizie
Should you hold or exit Catalyst Pharmaceuticals Inc. nowJobs Report & AI Forecast Swing Trade Picks - Newser
Heatmap analysis for Catalyst Pharmaceuticals Inc. and competitors2025 Price Momentum & Short-Term Swing Trade Alerts - Newser
Detecting support and resistance levels for Catalyst Pharmaceuticals Inc.Swing Trade & Reliable Volume Spike Trade Alerts - Newser
Will Catalyst Pharmaceuticals Inc. price bounce be sustainableMarket Activity Summary & Low Risk High Win Rate Stock Picks - Newser
How to monitor Catalyst Pharmaceuticals Inc. with trend dashboardsEntry Point & Free AI Powered Buy and Sell Recommendations - Newser
News impact scoring models applied to Catalyst Pharmaceuticals Inc.Portfolio Return Summary & Accurate Entry/Exit Alerts - Newser
Is Catalyst Pharmaceuticals Inc. building a consolidation baseJuly 2025 Recap & High Conviction Buy Zone Picks - Newser
Catalyst Pharmaceutical (CPRX) is a Strong Value Stock - AInvest
Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Value Stock - Yahoo Finance
Catalyst Pharmaceuticals, Inc. (CPRX) Secures FIRDAPSE Market Exclusivity Until 2035 - Insider Monkey
Statistical indicators supporting Catalyst Pharmaceuticals Inc.’s strength - Newser
Catalyst Pharmaceuticals Q2 Earnings Beat, Firdapse Revenues Rise Y/Y - MSN
Risk adjusted return profile for Catalyst Pharmaceuticals Inc. analyzedTrade Ideas & Real-Time Chart Breakout Alerts - Newser
Market reaction to Catalyst Pharmaceuticals Inc.’s recent news2025 Pullback Review & Weekly Market Pulse Alerts - Newser
Sector ETF performance correlation with Catalyst Pharmaceuticals Inc.July 2025 Opening Moves & Technical Pattern Alert System - Newser
How to recover losses in Catalyst Pharmaceuticals Inc. stock2025 Biggest Moves & Free Safe Capital Growth Stock Tips - Newser
Catalyst Pharmaceuticals Inc. stock prediction for this weekEarnings Risk Summary & Weekly Return Optimization Plans - Newser
Published on: 2025-08-28 14:59:31 - Newser
Using data models to predict Catalyst Pharmaceuticals Inc. stock movementJuly 2025 Drop Watch & Capital Efficient Trade Techniques - Newser
Rare Disease Leader Catalyst Pharmaceuticals Sets Four Major Healthcare Conference Appearances in September - Stock Titan
Catalyst Pharmaceuticals Announces Upcoming Participation in Major Investor Conferences - Quiver Quantitative
Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences - The Manila Times
Catalyst Pharmaceuticals Announces Management Participation in Investor Conferences. - AInvest
Catalyst Pharmaceuticals Inc Azioni (CPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.96%
1.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):